Mag-Amide
87/100
This product is generally safe
- Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
Label Data
2 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
500 mg
(3125% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 14.3× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
84 mg
(20% DV)
📊 Market median: 4002.0mg (1 products)
📚 20 studies (Tier A: 0, B: 2)
1000 mg
📊 Market median: 4002.0mg (1 products)
📚 20 studies (Tier A: 0, B: 2)
Other Ingredients
Vegetable Wax
Stearic Acid
Magnesium Stearate
Silica
Label Claims — Verification
❓
Nutrient
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Sugar Free
Product Information
📋 Directions for Use
Suggested Use: Take two (2) tablets daily with a full glass of water, preferably with a meal, or as directed by your healthcare practitioner.
⚠️ Warnings & Precautions
Consult your healthcare professional prior to use if you have or suspect a medical condition, are taking any medications, or are pregnant or nursing.
Keep out of reach of children.
Do not use if seal is broken or missing.
🧪 Formulation Notes
Magtein & Niacinamide
No salt, sugar, starch, preservatives, artificial color or flavorings.
Additional Information
Store in a cool, dry place.
Natural color variation occurs in tablets. Formulated for steady release over 3–5 hours.
Sustained release
Promotes brain health and cellular energy
500mg/250mg
17512
Product Details
UPC / SKU
7 29135 17512 3
DSLD Entry Date
2018-07-25
Product Type
Other Combinations
Form
Tablet or Pill
DSLD ID
177814
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100